Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness



Status:Recruiting
Healthy:No
Age Range:18 - 75
Updated:12/13/2018
Start Date:December 2018
End Date:March 2019
Contact:Vanda Pharmaceuticals
Email:clinicaltrials@vandapharma.com
Phone:202-734-3400

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Motion Sifnos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Randomized, double-blind, placebo-controlled study to be conducted in the United States in
subjects with motion sickness.


Inclusion Criteria:

- Male or non-pregnant, non-lactating female patients aged 18 - 75 years (inclusive);

- Body Mass Index (BMI) of ≥18 and ≤30 kg/m2;

- History or symptoms consistent with motion sickness

Exclusion Criteria:

- Chronic nausea due to condition other than motion sickness;

- A positive test for drugs of abuse at the screening or evaluation visits;

- Clinically significant deviation from normal clinical laboratory results
We found this trial at
1
site
Vanda Investigational Site
Santa Monica, California 90404
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials